mTORC1 and mTORC2 cooperatively cause hypermethylation of H3K27, which subsequently promotes tumor cell survival of glioblastoma both in vitro and in vivo, suggesting that dynamic regulation of histone methylation by mTOR complexes could be exploitable as a novel therapeutic target against this deadly tumor [167]. This evidence concerns the gene MTOR and neoplasm.